Cradle Health

Cradle Health is a biotechnology company reimagining the science and industry of cryopreservation. Founded around 2021 and backed by over $50 million in funding, Cradle has assembled a world-class interdisciplinary team to tackle the fundamental challenges of preserving biological tissue at ultra-low temperatures. A key milestone was achieved on February 13, 2024, when Cradle successfully vitrified neural tissue and confirmed its electrical activity after cryopreservation — a significant scientific advance. The company is backed by Metaplanet and is focused on developing cryopreservation technologies with broad applications across medicine, organ banking, and long-term biological storage.